AstraZeneca shares slide 9% after heart treatment disappoints in trial
Business

AstraZeneca shares slide 9% after heart treatment disappoints in trial

The Irish Times logoThe Irish Times

UK pharmaceutical company said Wainua drug did not meet goal of reducing cardiovascular deaths